Literature DB >> 26015468

Cardiology Patient Page. Chelation therapy: a new look at an old treatment for heart disease, particularly in diabetics.

Gervasio A Lamas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26015468      PMCID： PMC4448121          DOI： 10.1161/CIRCULATIONAHA.114.010774

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy.

Authors:  Gervasio A Lamas; Robin Boineau; Christine Goertz; Daniel B Mark; Yves Rosenberg; Mario Stylianou; Theodore Rozema; Richard L Nahin; L Terry Chappell; Lauren Lindblad; Eldrin F Lewis; Jeanne Drisko; Kerry L Lee
Journal:  Am Heart J       Date:  2014-04-02       Impact factor: 4.749

Review 2.  Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure.

Authors:  Natalia V Solenkova; Jonathan D Newman; Jeffrey S Berger; George Thurston; Judith S Hochman; Gervasio A Lamas
Journal:  Am Heart J       Date:  2014-07-22       Impact factor: 4.749

3.  The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT).

Authors:  Esteban Escolar; Gervasio A Lamas; Daniel B Mark; Robin Boineau; Christine Goertz; Yves Rosenberg; Richard L Nahin; Pamela Ouyang; Theodore Rozema; Allan Magaziner; Richard Nahas; Eldrin F Lewis; Lauren Lindblad; Kerry L Lee
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-11-19

4.  Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial.

Authors:  Gervasio A Lamas; Christine Goertz; Robin Boineau; Daniel B Mark; Theodore Rozema; Richard L Nahin; Lauren Lindblad; Eldrin F Lewis; Jeanne Drisko; Kerry L Lee
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272
  4 in total
  2 in total

Review 1.  Rationale for the Successful Management of EDTA Chelation Therapy in Human Burden by Toxic Metals.

Authors:  Maria Elena Ferrero
Journal:  Biomed Res Int       Date:  2016-11-08       Impact factor: 3.411

Review 2.  The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19.

Authors:  Artemio García-Escobar; Santiago Jiménez-Valero; Guillermo Galeote; Alfonso Jurado-Román; Julio García-Rodríguez; Raúl Moreno
Journal:  Heart Fail Rev       Date:  2021-01-06       Impact factor: 4.214
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.